Cargando…

A plasma telomeric cell-free DNA level in unaffected women with BRCA1 or/and BRCA2 mutations: a pilot study

Plasma cell-free DNA (cfDNA) is a small DNA fragment circulating in the bloodstream originating from both non-tumor- and tumor-derived cells. A previous study showed that a plasma telomeric cfDNA level decreases in sporadic breast cancer patients compared to controls. Tumor suppressor gene products...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dey, Shatovisha, Marino, Natascia, Bishop, Kanokwan, Dahlgren, Paige N., Shendre, Aditi, Storniolo, Anna Maria, He, Chunyan, Tanaka, Hiromi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790533/ https://www.ncbi.nlm.nih.gov/pubmed/29423116 http://dx.doi.org/10.18632/oncotarget.23767

Ejemplares similares

Development of a New Monochrome Multiplex qPCR Method for Relative Telomere Length Measurement in Cancer
por: Dahlgren, Paige N., et al.
Publicado: (2018)

Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA Mutation Carrier
por: Maeshima, Yurina, et al.
Publicado: (2016)

Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status
por: Killick, Emma, et al.
Publicado: (2014)

BRCA2 Haploinsufficiency in Telomere Maintenance
por: Gunnarsdottir, Soffía R., et al.
Publicado: (2021)

A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers
por: Guinan, Emer M, et al.
Publicado: (2013)

BRCA1 in the DNA damage response and at telomeres
por: Rosen, Eliot M.
Publicado: (2013)

Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic
por: Zimovjanova, Martina, et al.
Publicado: (2023)

Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
por: Lee, Eun-Gyeong, et al.
Publicado: (2019)

DNA damage repair is unaffected by mimicked heterozygous levels of BRCA2 in HT-29 cells
por: Tannenbaum, Brian, et al.
Publicado: (2007)

Dynamic interaction of BRCA2 with telomeric G-quadruplexes underlies telomere replication homeostasis
por: Lee, Junyeop, et al.
Publicado: (2022)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

BRCA2 and homologous recombination
por: Orelli, Brian J, et al.
Publicado: (2001)

Melanoma predisposition—A limited role for germline BRCA1 and BRCA2 variants
por: Adams, David J., et al.
Publicado: (2019)

Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells
por: Acharya, Samir, et al.
Publicado: (2014)

Analysis of alternative lengthening of telomere markers in BRCA1 defective cells
por: Kargaran, Parisa K., et al.
Publicado: (2016)

Assessing Psychological Morbidity in Cancer-Unaffected BRCA1/2 Pathogenic Variant Carriers: A Systematic Review
por: Isselhard, Anna, et al.
Publicado: (2023)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)

Scar-Free Laparoscopy in BRCA-Mutated Women
por: Restaino, Stefano, et al.
Publicado: (2022)

Effects of BRCA2 deficiency on telomere recombination in non-ALT and ALT cells
por: Sapir, Ester, et al.
Publicado: (2011)

BRCA2 Acts as RAD51 Loader to Facilitate Telomere Replication and Capping
por: Badie, Sophie, et al.
Publicado: (2010)

Epistatic Relationships in the BRCA1-BRCA2 Pathway
por: Scully, Ralph
Publicado: (2011)

A model of the BRCA1/BRCA2 network
por: Pujana, MA, et al.
Publicado: (2005)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020)

BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ
por: Liu, Yan, et al.
Publicado: (2019)

Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Odén, Lovisa, et al.
Publicado: (2016)

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2
por: Bernstein-Molho, Rinat, et al.
Publicado: (2022)

BRCA1 and BRCA2 mutations in Scotland and Northern Ireland
Publicado: (2003)

Clinical significance of large rearrangements in BRCA1 and BRCA2
por: Judkins, Thaddeus, et al.
Publicado: (2012)

Autoimmune response to PARP and BRCA1/BRCA2 in cancer
por: Zhu, Qing, et al.
Publicado: (2015)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
por: Li, Qianyan, et al.
Publicado: (2021)

Prediction of carrying a BRCA1 or BRCA2 mutation
por: Lee, Kyung-Hun
Publicado: (2023)

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers
por: Shimada, Satoko, et al.
Publicado: (2019)

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
por: Chenevix-Trench, Georgia, et al.
Publicado: (2007)

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
por: Julian-Reynier, Claire, et al.
Publicado: (2011)

Predictors of cardiopulmonary fitness in cancer-affected and -unaffected women with a pathogenic germline variant in the genes BRCA1/2 (LIBRE-1)
por: Berling-Ernst, A., et al.
Publicado: (2022)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tdj8bt641t6f5861f6voqnhg02